￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Acalatinib/Acalabrutinib: AstraZeneca’s innovative anti-cancer drug

2026-02-01 22:25:32

Check Details
Discussion on the monthly treatment cost of acalatinib/acalatinib

2026-02-01 22:25:32

Check Details
Acotinib/Acalabrutinib and Upadatinib: Therapeutic areas and comparison of effects of the two drugs

2026-02-01 22:25:32

Check Details
Is acotinib/acalabrutinib immune or targeted?

2026-02-01 22:25:32

Check Details
Success rate of lung cancer treated with acalabrutinib

2026-02-01 22:25:32

Check Details
Acotinib/Acalatinib price list

2026-02-01 22:25:32

Check Details
How much does acalatinib cost after medical insurance reimbursement?

2026-02-01 22:25:32

Check Details
Acalatinib/Acalatinib English name

2026-02-01 22:25:32

Check Details
Acalatinib/Acalabrutinib: a rising star in targeted therapy

2026-02-01 22:25:32

Check Details
The potential and current status of acotinib/acalabrutinib in the treatment of lung cancer

2026-02-01 22:25:32

Check Details
Akatinib/Acalatinib opens up new treatment path for lymphoma patients

2026-02-01 22:25:32

Check Details
The English name of acotinib/acalabrutinib and Acalabrutinib

2026-02-01 22:25:32

Check Details
Category
相关知识